Back to top
more

Eli Lilly and Company (LLY)

(Delayed Data from NYSE)

$87.18 USD

87.18
4,902,685

-0.05 (-0.06%)

Updated Oct 23, 2017 04:00 PM ET

Add to portfolio

3-Hold     3    

B Value | A Growth | F Momentum | B VGM

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 25.71%
2 Buy 18.12%
3 Hold 9.91%
4 Sell 5.49%
5 Strong Sell 2.29%
S&P 500 9.79%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Balance Sheet

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

Research for LLY

   

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

Fiscal Year End for Eli Lilly and Company falls in the month of December.

All items in Millions except Per Share data.

12/31/2016 12/31/2015 12/31/2014 12/31/2013 12/31/2012
Assets          
Cash & Equivalents 6,039 4,452 4,827 5,397 5,684
Receivables 4,766 4,072 3,801 4,023 3,888
Notes Receivable 0 0 0 0 0
Inventories 3,562 3,446 2,740 2,929 2,644
Other Current Assets 735 604 812 756 822
Total Current Assets 15,101 12,574 12,180 13,105 13,039
Net Property & Equipment 8,253 8,054 7,964 7,976 7,760
Investments & Advances 5,208 3,647 4,569 7,625 6,313
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 8,331 9,075 4,642 4,331 4,753
Deposits & Other Assets 1,914 2,221 7,823 2,213 2,534
Total Assets 38,806 35,569 37,178 35,249 34,399
Liabilities & Shareholders Equity 12/31/2016 12/31/2015 12/31/2014 12/31/2013 12/31/2012
Notes Payable 1,937 6 2,689 1,013 12
Accounts Payable 1,349 1,338 1,128 1,119 1,188
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 0 0 0 0 0
Income Taxes Payable 119 359 1,560 1,047 1,192
Other Current Liabilities 7,581 6,526 5,831 5,738 5,998
Total Current Liabilities 10,987 8,230 11,208 8,917 8,390
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 8,368 7,972 5,368 4,200 5,519
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 5,371 4,777 5,215 4,491 5,716
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 24,725 20,979 21,790 17,608 19,625
Shareholders Equity 12/31/2016 12/31/2015 12/31/2014 12/31/2013 12/31/2012
Preferred Stock 0 0 0 0 0
Common Stock (Par) 689 691 695 699 717
Capital Surplus 5,641 5,552 5,292 5,050 4,963
Retained Earnings 16,046 16,012 16,483 16,992 16,088
Other Equity -8,214 -7,575 -6,990 -5,007 -6,802
Treasury Stock 81 90 91 94 192
Total Shareholder's Equity 14,081 14,590 15,388 17,641 14,774
Total Liabilities & Shareholder's Equity 38,806 35,569 37,178 35,249 34,399
Total Common Equity 14,081 14,590 15,388 17,641 14,774
Shares Outstanding 1,103.90 1,108.00 1,113.40 1,126.60 1,160.40
Book Value Per Share 12.76 13.17 13.82 15.66 12.73

Fiscal Year End for Eli Lilly and Company falls in the month of December.

All items in Millions except Per Share data.

9/30/2017 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Assets          
Cash & Equivalents NA 5,434 3,506 6,039 4,227
Receivables NA 4,956 4,614 4,766 4,521
Notes Receivable NA 0 0 0 0
Inventories NA 4,346 4,035 3,562 3,881
Other Current Assets NA 1,010 822 735 757
Total Current Assets NA 15,747 12,976 15,101 13,386
Net Property & Equipment NA 8,583 8,426 8,253 8,252
Investments & Advances NA 5,723 5,298 5,208 5,027
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 8,833 8,905 8,331 8,646
Deposits & Other Assets NA 2,061 2,020 1,914 2,279
Total Assets NA 40,947 37,624 38,806 37,590
Liabilities & Shareholders Equity 9/30/2017 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Notes Payable NA 2,444 2,609 1,937 642
Accounts Payable NA 1,257 1,220 1,349 1,161
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 236 122 119 183
Other Current Liabilities NA 7,357 6,497 7,581 6,287
Total Current Liabilities NA 11,295 10,448 10,987 8,273
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 9,868 7,638 8,368 8,707
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 5,435 5,371 4,994
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 26,777 23,521 24,725 21,975
Shareholders Equity 9/30/2017 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 689 690 689 690
Capital Surplus NA 5,686 5,618 5,641 5,649
Retained Earnings NA 15,590 15,877 16,046 16,602
Other Equity NA -7,719 -8,005 -8,214 -7,244
Treasury Stock NA 76 76 81 81
Total Shareholder's Equity NA 14,170 14,104 14,081 15,616
Total Liabilities & Shareholder's Equity NA 40,947 37,624 38,806 37,590
Total Common Equity 0 14,170 14,104 14,081 15,616
Shares Outstanding 1,100.90 1,100.90 1,103.30 1,103.90 1,103.90
Book Value Per Share 0.00 12.87 12.78 12.76 14.15